REMEVi review
By The Dose Brief DeskUpdated
English- and Spanish-language GLP-1 care with four-week billing, published prepaid totals and no advertised dose upcharge.
- Semaglutide
$199 / 4 weeks
24-week option: $954 upfront ($159 per four weeks).
Full price details
$199 every 4 weeks; $954 prepaid for 24 weeks ($159 per 4 weeks)
- Tirzepatide
$269 / 4 weeks
24-week option: $1,350 upfront ($225 per four weeks).
Full price details
$269 every 4 weeks; $1,350 prepaid for 24 weeks ($225 per 4 weeks)
- Coverage
- 49 states and DC; excludes Louisiana
- Brand-name
- Not confirmed
Prices checked against REMEVi's published terms in . Providers change pricing without notice — check the current figure before you buy.
REMEVi in depth
REMEVi’s most useful distinction is its English- and Spanish-language service, including intake, clinical evaluation, dosing instructions, portal support and billing. That can matter more than a small headline-price difference if you want to discuss treatment in Spanish. The program serves 49 states and Washington, DC, excluding Louisiana; it is not an all-50-state option.
The flexible injection plans cost $199 for semaglutide or $269 for tirzepatide every four weeks. For 12 weeks, the published upfront totals are $507 and $699. For 24 weeks, they are $954 and $1,350, equivalent to $159 and $225 per four weeks. Four weeks is 28 days, not a calendar month. REMEVi explicitly advertises the same price at every dose within the selected plan, so the main price decision is commitment length rather than dose escalation.
The package includes clinical care, prescribed medication, supplies, shipping and clinician-required GLP-1 labs, without a separate membership fee. By contrast, Collective charges a required annual membership separately from its monthly medication price. The pricing page identifies OpenLoop clinicians and names Red Rock, HealthWarehouse, Precision Medicine and Triad Rx as pharmacy partners. Those disclosures help you ask about the actual pharmacy assignment; they are not an independent verification of every clinician or prescription.
A compounded dissolving semaglutide tablet is also offered: $249 every four weeks, $687 for 12 weeks or $1,290 for 24 weeks. It is not an FDA-approved branded tablet. REMEVi’s Ozempic, Wegovy and Zepbound comparison pages should not be mistaken for offers to dispense those brands.
Cancellation requires at least 72 hours before the billing date to stop the next charge. The policy provides a full refund within the first 72 hours only when no services have been provided, and describes refunds for medical disqualification. For longer prepaid terms, refunds cover months with no medication shipped; shipped supplies are excluded. The shorter plan is therefore worth considering if you are still assessing tolerability or do not want a large upfront commitment. A separate results guarantee has adherence conditions and should not be read as a promised clinical outcome.
Sources we checked
Public program pages and terms, checked October 2026. We have not enrolled in treatment or independently tested the medication.
This source update covers the review text and stated program terms. The existing numerical score has not been recalculated from this check; it should not be read as a new validation of every score factor.
The scorecard
REMEVi scored on our six Brief Score factors. See the methodology.
What we like
- English and Spanish support from intake through billing
- Publishes full prepaid totals and explicitly holds price constant across doses within a plan
- Clinician-required GLP-1 labs, supplies and shipping included
- Compounded oral semaglutide is available alongside injections
The caveats
- Lowest rate requires 24 weeks paid upfront
- Four-week billing is not calendar-month billing
- Unavailable in Louisiana; no verified branded-medication pathway
- Refunds depend on timing and whether medication has shipped
The brief
Best for: People who value Spanish-language support and want to compare a flexible four-week plan with a clearly priced longer commitment. English- and Spanish-language GLP-1 care with four-week billing, published prepaid totals and no advertised dose upcharge.
Ranked #9 of 546 providers we reviewed — compare with CoreAge Rx, for comparison.
Before you decide
The questions readers ask next after reading about REMEVi.
Closest here
The providers scoring nearest REMEVi — read each current assessment before choosing care.
Weighing REMEVi against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs REMEVi, and every provider that outranks it is listed on the REMEVi alternatives ranking.
- #6HealthRX— Compounded injectable GLP-1 care with visible plan tables, but conflicting prices and supply-versus-billing periods that need checking before payment.86/100
- #7Sprout Health— A compounded GLP-1 provider with four-week and annual offers, plus a separate tablet-and-injection program whose advertised prices differ.86/100
- #8Invigor Medical— Invigor Medical now redirects to Try Invigor, which advertises compounded GLP-1 programs with an early cancellation cutoff and prescription-specific pricing.88/100
- #10Ro— Ro combines FDA-approved GLP-1 access and insurance support with a separate membership; compare the full bill, not the medication price alone.87/100
- #11Ondra Health— Compounded injections with several pharmacy options, $149/$219 monthly plans and lower annual rates that require full prepayment.87/100
- #12Vaylen— Prepaid GLP-1 plans with an oral option, but coverage and clinical-provider details need clarification.87/100
More providers we track (24)
- #1 CoreAge Rx94
- #2 Eden91
- #3 Sesame Care87
- #4 ShedRx87
- #5 Trimi89
- #13 Vytora Health87
- #14 No BS RX87
- #15 yourEra84
- #16 Strut Health84
- #17 Effecty86
- #18 NiceRx86
- #19 Curex86
- #20 Amazon One Medical86
- #21 MadeMed86
- #22 Telos Rx85
- #23 Enhance MD85
- #24 AgelessRx85
- #25 Precision Telemed85
- #26 BetterMe Rx85
- #27 Hims & Hers85
- #28 TeleCareSpot85
- #29 RestorLife Med85
- #30 Gala Health82
- #31 Direct Meds82
514 more are filed too — see every provider we track, ranked.
Pricing, states and verification reflect REMEVi's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on REMEVi's site. Not medical advice; see our disclosure.